Article
Multimodal AI fuses proteomic and EHR data for rational prioritization of protein biomarkers in diabetic retinopathy
2026-02-24
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Purpose</h4> There is a need for novel therapies for diabetic retinopathy (DR) because existing therapies treat only certain features of DR and do not work optimally for all patients. While proteomic studies provide insight into disease pathobiology, they are often limited to small sample sizes due to high costs, limiting their generalizability and reproducibility. Moreover, they often yiel...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b44d8a30-64fd-5bba-be47-d8d98bfdb035
- DOI
- 10.64898/2026.02.23.26346903
